Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Burnaby
- Most recent report
- 10-Q, filed Nov 9, 2026
- Incorporated
- N/A
- Filings on record
- 805 filings
- On EDGAR
- CIK 1582313
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 52
News 8 of 145
Prospectuses and Registrations 8 of 60
- S-8 Registration statement for an employee plan Nov 9, 2026
- S-8 POS Post-effective amendment to an employee plan registration Jun 3, 2026
- S-8 POS Post-effective amendment to an employee plan registration Jun 3, 2026
- S-8 POS Post-effective amendment to an employee plan registration Jun 3, 2026
- S-8 POS Post-effective amendment to an employee plan registration Jun 3, 2026
- S-8 POS Post-effective amendment to an employee plan registration Jun 3, 2026
- S-8 POS Post-effective amendment to an employee plan registration Jun 3, 2026
- S-8 POS Post-effective amendment to an employee plan registration Jun 3, 2026
Proxies 8 of 14
- DEFA14A Extra proxy material Apr 22, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 22, 2026
- DEFA14A Extra proxy material Apr 24, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 24, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 26, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 27, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2022
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2021
Ownership 8 of 485
- SCHEDULE 13G/A Large holder reported a passive stake, amended Nov 6, 2026
- SCHEDULE 13G Large holder reported a passive stake Nov 6, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Nov 5, 2026
- 4 Insider reported a trade Oct 16, 2026
- 4 Insider reported a trade Oct 1, 2026
- 4 Insider reported a trade Oct 1, 2026
- 4 Insider reported a trade Sep 3, 2026
- 4 Insider reported a trade Aug 31, 2026
Other 8 of 49
- ARS Annual report sent to shareholders Apr 22, 2026
- ARS Annual report sent to shareholders Apr 24, 2025
- ARS Annual report sent to shareholders Apr 26, 2024
- ARS Annual report sent to shareholders Apr 27, 2023
- CT ORDER Sep 1, 2020
- EFFECT Notice that a registration became effective Jun 12, 2020
- CORRESP Reply to SEC staff Jun 10, 2020
- UPLOAD Comment letter from SEC staff Jun 10, 2020
Everything here comes from Xenon Pharmaceuticals Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.